Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Cattran

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of the American Society of Nephrology : JASN|July 8, 2015
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE SubjectsMatthew G Sampson, Catherine C Robertson, Sebastian Martini, et al.
JCI Insight|February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responsesElissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative GlomerulonephritisHannah J Lomax-Browne, Nicholas R Medjeral-Thomas, Sean J Barbour, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GNSanjeev Sethi, Mark Haas, Glen S Markowitz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
The Journal of Clinical Investigation|November 26, 2013
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruptionShazia Ashraf, Heon Yung Gee, Stephanie Woerner, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility, Ian S D Roberts, H Terence Cook, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification, Daniel C Cattran, Rosanna Coppo, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of the American Society of Nephrology : JASN|July 8, 2015
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE SubjectsMatthew G Sampson, Catherine C Robertson, Sebastian Martini, et al.
JCI Insight|February 8, 2022
Immunoglobulin A nephropathy is characterized by anticommensal humoral immune responsesElissa G Currie, Bryan Coburn, Elisa A Porfilio, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative GlomerulonephritisHannah J Lomax-Browne, Nicholas R Medjeral-Thomas, Sean J Barbour, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Journal of the American Society of Nephrology : JASN|November 15, 2015
Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GNSanjeev Sethi, Mark Haas, Glen S Markowitz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
The Journal of Clinical Investigation|November 26, 2013
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruptionShazia Ashraf, Heon Yung Gee, Stephanie Woerner, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility, Ian S D Roberts, H Terence Cook, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Kidney International|July 3, 2009
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification, Daniel C Cattran, Rosanna Coppo, et al.
Pageof 11